Product Certification&
    Enterprise Certification

  • Ms.Yan
    Tel: +86-18013506594

  • Mobile:+86-18013506594
  • Tel:+86-18013506594
  • Fax:
  • URL:http://www.betterbiochem.com
  • Province/state:SHANGHAI
  • City:SHANGHAI
  • Street:No. 8 Building, 18 nong, Xi Yingnan Road, Pudong, Shanghai,China
  • MaxCard:
Home > Products >  1802220-02-5 exporter Competitive price 1802220-02-5 low price 1802220-02-5 TPX-0005

1802220-02-5 exporter Competitive price 1802220-02-5 low price 1802220-02-5 TPX-0005 CAS NO.1802220-02-5

  • FOB Price: USD: /Gram Get Latest Price
  • Min.Order: 1 Gram
  • Payment Terms: T/T,MoneyGram,Other
  • Available Specifications:

    99%(1-5)Gram98%(1-5)Gram

  • Product Details

Keywords

  • 1802220-02-5 exporter
  • Competitive price 1802220-02-5
  • low price 1802220-02-5 TPX-0005

Quick Details

  • ProName: 1802220-02-5 exporter Competitive pric...
  • CasNo: 1802220-02-5
  • Molecular Formula: C18H18FN5O2
  • Appearance: Powder
  • Application: Scientific research
  • DeliveryTime: Prompt
  • PackAge: As required
  • Port: Shanghai
  • ProductionCapacity: 1000 Gram/Week
  • Purity: 98%
  • Storage: keep sealed and keep from direct light
  • Transportation: By Sea/Air/FedEx
  • LimitNum: 1 Gram
  • Moisture Content: N/A
  • Impurity: N/A
  • Grade: Industrial Grade,Pharma Grade

Superiority

1802220-02-5 exporter Competitive price 1802220-02-5 low price  TPX-0005

TPX-0005 is a multi-kinase inhibitor that inhibits TrkA, TrkB, and TrkC (IC50s = 0.83, 0.05, and 0.1 nM, respectively) as well as C-ros oncogene 1 (ROS1; IC50 = 0.07 nM).It inhibits a variety of other kinases, including ALK, JAK2, LYN, Src, and FAK (IC50s = 1.04, 1.04, 1.66, 5.3, and 6.96 nM, respectively). It inhibits proliferation of PC-9, H1975, 11-18, HCC4006, and HCC827 lung cancer cells (IC50s = 100, 100, 150, 148, and 430 nM, respectively) with additive or synergistic effects when used in combination with gefitinib, afatinib, PF-299804 , or osimertinib. TPX-0005 (30 mg/kg) reduces tumor growth in PC-9 and H1975 mouse xenograft models and potentiates the effect of osimertinib in these models.

TPX-0005 is an orally available and potent ATP-competitive inhibitor of ALK/ROS1/TRK (IC50= 5.3 nM for SRC, IC50= 1.01 nM, 1.26 nM and 1.08 nM for mutant ALKs including WT ALK, ALK G1202R and ALK L1196M, respectively).

Details

TPX-0005 is a multi-kinase inhibitor that inhibits TrkA, TrkB, and TrkC (IC50s = 0.83, 0.05, and 0.1 nM, respectively) as well as C-ros oncogene 1 (ROS1, IC50 = 0.07 nM). It inhibits a variety of other kinases, including ALK, JAK2, LYN, Src, and FAK (IC50s = 1.04, 1.04, 1.66, 5.3, and 6.96 nM, respectively). It inhibits proliferation of PC-9, H1975, 11-18, HCC4006, and HCC827 lung cancer cells (IC50s = 100, 100, 150, 148, and 430 nM, respectively) with additive or synergistic effects when used in combination with gefitinib (Cay-13166), afatinib (Cay-11492), PF-299804 (dacomitinib, Cay-9001879), or osimertinib. TPX-0005 (30 mg/kg) reduces tumor growth in PC-9 and H1975 mouse xenograft models and potentiates the effect of osimertinib in these models. Formal Name: (7S,13R)-11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-1,15-etheno-1H-pyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one. CAS Number: 1802220-02-5. Molecular Formula: C18H18FN5O2. Formula Weight: 355.4. Purity: >98%. Formulation: A crystalline solid. Solubility: DMF: 1 mg/ml, DMSO: 0.2 mg/ml. lambdamax: 222, 258 nm. SMILES: C[C@@H](NC1=NC2=C3C=NN2C=C1)C4=CC(F)=CC=C4O[C@@H](C)CNC3=O. InChi Code: InChI=1S/C18H18FN5O2/c1-10-8-20-18(25)14-9-21-24-6-5-16(23-17(14)24)22-11(2)13-7-12(19)3-4-15(13)26-10/h3-7,9-11H,8H2,1-2H3,(H,20,25)(H,22,23)/t10-,11+/m0/s1. InChi Key: FIKPXCOQUIZNHB-WDEREUQCSA-N.

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog